JPS51148010A - Crystalline salt - Google Patents

Crystalline salt

Info

Publication number
JPS51148010A
JPS51148010A JP4016076A JP4016076A JPS51148010A JP S51148010 A JPS51148010 A JP S51148010A JP 4016076 A JP4016076 A JP 4016076A JP 4016076 A JP4016076 A JP 4016076A JP S51148010 A JPS51148010 A JP S51148010A
Authority
JP
Japan
Prior art keywords
crystalline salt
crystalline
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4016076A
Other languages
Japanese (ja)
Inventor
Bofuii Jiyamiison Uiriamu
Pikuton Suwan Buraian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of JPS51148010A publication Critical patent/JPS51148010A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP4016076A 1975-04-10 1976-04-08 Crystalline salt Pending JPS51148010A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1467475A GB1546757A (en) 1975-04-10 1975-04-10 Crystalline cephalosporin salts

Publications (1)

Publication Number Publication Date
JPS51148010A true JPS51148010A (en) 1976-12-18

Family

ID=10045536

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4016076A Pending JPS51148010A (en) 1975-04-10 1976-04-08 Crystalline salt

Country Status (6)

Country Link
JP (1) JPS51148010A (en)
CA (1) CA1079719A (en)
CH (1) CH610329A5 (en)
ES (1) ES446743A1 (en)
GB (1) GB1546757A (en)
NL (1) NL188351C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0665254A (en) * 1982-10-20 1994-03-08 Bristol Myers Squibb Co Ceforanide derivative

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5095107A (en) * 1990-11-05 1992-03-10 Eli Lilly And Company Process for cleavage of esters during the production of cephalosporins
US5302711A (en) * 1992-02-18 1994-04-12 Eli Lilly And Company Ester cleavage process for use with β-lactams

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0665254A (en) * 1982-10-20 1994-03-08 Bristol Myers Squibb Co Ceforanide derivative

Also Published As

Publication number Publication date
NL188351C (en) 1992-06-01
ES446743A1 (en) 1977-06-01
GB1546757A (en) 1979-05-31
NL7603617A (en) 1976-10-12
CA1079719A (en) 1980-06-17
CH610329A5 (en) 1979-04-12
NL188351B (en) 1992-01-02

Similar Documents

Publication Publication Date Title
GB1539006A (en) Aminoalkylammonium compound
JPS57112388A (en) 1-sulfonylbenzimidazole compound
GB1553886A (en) Silicon-tin compounds
JPS51113900A (en) Riphamycin compound
JPS5247911A (en) Pilocarpine salt
ZA765652B (en) New prostaglandin salt
GB1557482A (en) Substituted tetranorprostaglandins
JPS5217472A (en) Substituted nnalkylimidazole derivatives
JPS51113829A (en) Aluminium salt
IL49100A0 (en) Antibiotic crystalline form
JPS5223076A (en) Antiiinflammatory compound
ZA764267B (en) Sulphine compounds
GB1544103A (en) 3-acyloxymethyl-cephem compounds
JPS51143699A (en) Riphamycin compound
JPS5236665A (en) 44dithioo33imide azethizinee 22one compound
JPS51115450A (en) Phosphorrcontaining compounds
JPS5231062A (en) Perfluoroalkylthionorbornane compound
ZA782655B (en) Salt
JPS5278869A (en) Thienylpolyene compound
JPS5285106A (en) Carbamateesulphenyllcarbamoylfluoride compounds
ZM576A1 (en) Compounds
JPS5268128A (en) Isothiourea derivatives
JPS5296718A (en) Novel piperaziniluracil salt
ZA767330B (en) A crystalline sodium salt
JPS51148010A (en) Crystalline salt